Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Provided by: Canadian Cardiac Oncology Network | International CardiOncology Society
In collaboration with: Ted Rogers Centre for Heart Research
The GCOS summit models a leading-edge interdisciplinary approach to preventative and targeted medicine in Cardio-Oncology. This year, we are expecting 600 international, interdisciplinary health care professionals to be in attendance in a hybrid meeting format (in-person and virtual), and will review the most recent literature and research on prevention, treatment and monitoring strategies in Cardio-Oncology as well as to provide a forum for new research collaborations and networking. The University of Toronto will accredit this year’s summit.
We invite abstract submissions for the Global Cardio-Oncology Summit on the prevention, management and treatment of cardiac complications related to oncology therapy.
Dr. Christine Brezden-Masley
Co-Chair, GCOS 2022
Medical Oncologist
Sinai Health System
Toronto, Ontario, Canada
Dr. Dinesh Thavendiranathan
Co-Chair, GCOS 2022
Cardiologist
Toronto General Hospital
Toronto, Ontario, Canada